.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.
    Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45
    Pub: 2008 Aug Epub: 2008 Jun 6
    • Salazar N
    • Gueimonde M
    • Hernández-Barranco AM
    • Ruas-Madiedo P
    • de los Reyes-Gavilán CG

  2. A probiotics-containing biscuit modulates the intestinal microbiota in the elderly.
    The journal of nutrition, health & aging (J Nutr Health Aging ) Vol: 17 Issue 2 Pages: 166-72
    Pub: 2013 Feb Epub:
    • Rampelli S
    • Candela M
    • Severgnini M
    • Biagi E
    • Turroni S
    • Roselli M
    • Carnevali P
    • Donini L
    • Brigidi P

  3. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
    Journal of periodontology (J Periodontol ) Vol: 88 Issue 2 Pages: 197-208
    Pub: 2017 Feb Epub: 2016 Sep 23
    • Oliveira LF
    • Salvador SL
    • Silva PH
    • Furlaneto FA
    • Figueiredo L
    • Casarin R
    • Ervolino E
    • Palioto DB
    • Souza SL
    • Taba M Jr
    • Novaes AB Jr
    • Messora MR

  4. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.
    FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 362 Issue 21 Pages:
    Pub: 2015 Nov Epub: 2015 Sep 28
    • Rios-Covian D
    • Gueimonde M
    • Duncan SH
    • Flint HJ
    • de los Reyes-Gavilan CG

  5. Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection.
    Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 52 Issue 11 Pages: 955-62
    Pub: 2014 Nov Epub: 2014 Oct 3
    • Kim JE
    • Kim MS
    • Yoon YS
    • Chung MJ
    • Yum DY

  6. Additional sources and private correspondance
    Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12
    Pub: 2018 Epub:
  7. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.
    Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 8770
    Pub: 2017 Aug 18 Epub: 2017 Aug 18
    • Fang D
    • Shi D
    • Lv L
    • Gu S
    • Wu W
    • Chen Y
    • Guo J
    • Li A
    • Hu X
    • Guo F
    • Ye J
    • Li Y
    • Li L

  8. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
    Scientific Reports (Sci Rep ) Vol: 7 Issue Pages: 8770
    Pub: 2017 Aug 18 Epub: 2017 Aug 18
    • Fang D
    • Shi D
    • Lv L
    • Gu S
    • Wu W
    • Chen Y
    • Guo J
    • Li A
    • Hu X
    • Guo F
    • Ye J
    • Li Y
    • Li L

  9. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21
    Pub: 2015 Apr Epub:
    • Shadnoush M
    • Hosseini RS
    • Khalilnezhad A
    • Navai L
    • Goudarzi H
    • Vaezjalali M

  10. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
    Scientific Reports (Sci Rep ) Vol: 7 Issue Pages: 8770
    Pub: 2017 Aug 18 Epub: 2017 Aug 18
    • Fang D
    • Shi D
    • Lv L
    • Gu S
    • Wu W
    • Chen Y
    • Guo J
    • Li A
    • Hu X
    • Guo F
    • Ye J
    • Li Y
    • Li L

Full list available by paid subscriptions

For More information see this summary.